StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Łast chance for these cheap shares...

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Jul 07, 2021 9:16am

107 Views

Post# 33504439

RE:RE:Łast chance for these cheap shares...

Q2 August 16

LithLover wrote: Financials are not due at the end of the month. Q2 2021 financials are due Aug 16, 2021. Q3 2021 are due Nov 15, 2021.

Care deal to close end of July 2021.

https://www.osc.ca/en/industry/companies/reporting-issuer-and-issuer-forms/filing-due-dates-calendar-annual-and-interim-filings-reporting-issuers

gojotv! wrote: And everybody knows it.
That's why today's first big buy raised the price. Stop-losses and nerves got triggered, and the vulture swooped in.
Don't make the same mistake...
Hold on for this week's ride to th $0.60's!
Financials at month's end will take us even higher!
Cheeres!